Advertisement
Advertisement
FTRE
Fortrea Holdings Inc. Common Stock
14.47
USDSponsored
-0.14
-0.96%
May 13, 15:59 UTC -4
Closed
Pre-Market
14.47
0.00
0.00%
FTRE Earnings Reports
Positive Surprise Ratio
FTRE beat 4 of 11 last estimates.
36%
Next Report
Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$662.49M
/$0.17
Implied change from Q1 26 (Revenue/ EPS)
+4.08%
/+6.25%
Implied change from Q2 25 (Revenue/ EPS)
-6.73%
/-10.53%
Fortrea Holdings Inc. Common Stock earnings per share and revenue
On May 05, 2026, FTRE reported earnings of 0.16 USD per share (EPS) for Q1 26, beating the estimate of 0.04 USD, resulting in a 241.15% surprise. Revenue reached 636.50 million, compared to an expected 637.91 million, with a -0.22% difference. The market reacted with a +18.61% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 11 analysts forecast an EPS of 0.17 USD, with revenue projected to reach 662.49 million USD, implying an increase of 6.25% EPS, and increase of 4.08% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Kamada Ltd
Report Date
May 13, 2026 For Q1 26
Estimate
$0.11
Actual
$0.07
Surprise
-40.32%
Abeona Therapeutics Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.36
Actual
-$0.30
Surprise
+17.31%
Milestone Pharmaceuticals Inc. Common Shares
Report Date
May 13, 2026 For Q1 26
Estimate
$0.31
Actual
-$0.20
Surprise
-163.94%
Spero Therapeutics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.13
Surprise
+29.19%
Equillium, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.06
Surprise
-34.53%
Spruce Biosciences, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$8.99
Actual
-$8.94
Surprise
+0.58%
BeyondSpring Inc. Ordinary Shares
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.05
Surprise
-
Tango Therapeutics, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.32
Surprise
-0.13%
Longeveron Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.16
Actual
-$0.19
Surprise
-12.89%
Bionano Genomics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.96
Actual
-$0.76
Surprise
+21.57%
FAQ
What were Fortrea Holdings Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Fortrea Holdings Inc. Common Stock reported EPS of $0.16, beating estimates by 241.15%, and revenue of $636.50M, -0.22% below expectations.
How did the market react to Fortrea Holdings Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 18.61%, changed from $12.25 before the earnings release to $14.53 the day after.
When is Fortrea Holdings Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 04, 2026.
What are the forecasts for Fortrea Holdings Inc. Common Stock's next earnings report?
Based on 11
analysts, Fortrea Holdings Inc. Common Stock is expected to report EPS of $0.17 and revenue of $662.49M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement